93 related articles for article (PubMed ID: 30686569)
1. Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part II: Obstetric Antiphospholipid Syndrome and Special Situations.
Cáliz Cáliz R; Díaz Del Campo Fontecha P; Galindo Izquierdo M; López Longo FJ; Martínez Zamora MÁ; Santamaria Ortiz A; Amengual Pliego O; Cuadrado Lozano MJ; Delgado Beltrán MP; Ortells LC; Pérez ECC; Rego GD; Corral SG; Varela CF; López MM; Nishishinya B; Navarro MN; Testa CP; Pérez HS; Silva-Fernández L; Taboada VMM
Reumatol Clin (Engl Ed); 2020; 16(2 Pt 2):133-148. PubMed ID: 30686569
[TBL] [Abstract][Full Text] [Related]
2. Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality.
Udry S; Latino JO; Perez SM; Belizna C; Aranda F; Esteve-Valverde E; Wingeyer SP; Romero DSF; Alijotas-Reig J; de Larrañaga G
Clin Rheumatol; 2024 May; 43(5):1615-1622. PubMed ID: 38436770
[TBL] [Abstract][Full Text] [Related]
3. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023.
Meca-Lallana JE; Martínez Yélamos S; Eichau S; Llaneza MÁ; Martín Martínez J; Peña Martínez J; Meca Lallana V; Alonso Torres AM; Moral Torres E; Río J; Calles C; Ares Luque A; Ramió-Torrentà L; Marzo Sola ME; Prieto JM; Martínez Ginés ML; Arroyo R; Otano Martínez MÁ; Brieva Ruiz L; Gómez Gutiérrez M; Rodríguez-Antigüedad Zarranz A; Sánchez-Seco VG; Costa-Frossard L; Hernández Pérez MÁ; Landete Pascual L; González Platas M; Oreja-Guevara C
Neurologia (Engl Ed); 2024 Mar; 39(2):196-208. PubMed ID: 38237804
[TBL] [Abstract][Full Text] [Related]
4. Stroke in a Patient With Antiphospholipid Syndrome.
Zuluaga-Gomez M; Quintero-Gutierrez L; González-Arroyave D; Ardila CM
Cureus; 2024 Mar; 16(3):e56897. PubMed ID: 38659540
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid syndrome: state of the art on clinical practice guidelines.
Limper M; Scirè CA; Talarico R; Amoura Z; Avcin T; Basile M; Burmester G; Carli L; Cervera R; Costedoat-Chalumeau N; Doria A; Dörner T; Fonseca JE; Galetti I; Hachulla E; Launay D; Lourenco F; Macieira C; Meroni P; Montecucco CM; Moraes-Fontes MF; Mouthon L; Nalli C; Ramoni V; Tektonidou M; van Laar JM; Bombardieri S; Schneider M; Smith V; Vieira A; Cutolo M; Mosca M; Tincani A
RMD Open; 2018; 4(Suppl 1):e000785. PubMed ID: 30402272
[TBL] [Abstract][Full Text] [Related]
6. Added IMPACT: The first successful natural birth using certolizumab in obstetric APS.
Madenidou AV; Kither H; Dyball S; Bruce IN; Tower C
Thromb Res; 2024 Jul; 241():109088. PubMed ID: 38970993
[No Abstract] [Full Text] [Related]
7. A bridge over troubled waters: Anti-inflammatory therapy for patients with refractory obstetric antiphospholipid syndrome?
Schreiber K; Piazza G; Hunt BJ
Thromb Res; 2021 Nov; 207():55-57. PubMed ID: 34547612
[No Abstract] [Full Text] [Related]
8. Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment.
Cáliz Cáliz R; Díaz Del Campo Fontecha P; Galindo Izquierdo M; López Longo FJ; Martínez Zamora MÁ; Santamaría Ortiz A; Amengual Pliego O; Cuadrado Lozano MJ; Delgado Beltrán MP; Carmona Ortells L; Cervantes Pérez EC; Díaz-Cordovés Rego G; Garrote Corral S; Fuego Varela C; Martín López M; Nishishinya B; Novella Navarro M; Pereda Testa C; Sánchez Pérez H; Silva-Fernández L; Martínez Taboada VM
Reumatol Clin (Engl Ed); 2020; 16(2 Pt 1):71-86. PubMed ID: 30713012
[TBL] [Abstract][Full Text] [Related]
9. EULAR recommendations for the management of antiphospholipid syndrome in adults.
Tektonidou MG; Andreoli L; Limper M; Amoura Z; Cervera R; Costedoat-Chalumeau N; Cuadrado MJ; Dörner T; Ferrer-Oliveras R; Hambly K; Khamashta MA; King J; Marchiori F; Meroni PL; Mosca M; Pengo V; Raio L; Ruiz-Irastorza G; Shoenfeld Y; Stojanovich L; Svenungsson E; Wahl D; Tincani A; Ward MM
Ann Rheum Dis; 2019 Oct; 78(10):1296-1304. PubMed ID: 31092409
[TBL] [Abstract][Full Text] [Related]
10. Management of maternal antiphospholipid syndrome.
Fernandes MA; Gerardi MC; Andreoli L; Tincani A
Clin Exp Rheumatol; 2020; 38(1):149-156. PubMed ID: 31287415
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy Control in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Part 1: Infertility, Ovarian Preservation and Preconception Assessment. Consensus Document of the Spanish Society of Gynaecology and Obstetrics (SEGO), the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Rheumatology (SER).
Espinosa G; Galindo-Izquierdo M; Marcos Puig B; Casellas Caro M; Delgado Beltrán P; Martínez López JA; Martínez Sánchez N; Robles-Marhuenda A; Rodríguez Almaraz E; Sáez-Comet L; Ugarte A; Vela-Casasempere P; Bartha JL; Ruiz-Irastorza G; Martínez-Taboada VM
Reumatol Clin (Engl Ed); 2021 Feb; 17(2):61-66. PubMed ID: 31784396
[TBL] [Abstract][Full Text] [Related]
12. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Nash P; Kerschbaumer A; Dörner T; Dougados M; Fleischmann RM; Geissler K; McInnes I; Pope JE; van der Heijde D; Stoffer-Marx M; Takeuchi T; Trauner M; Winthrop KL; de Wit M; Aletaha D; Baraliakos X; Boehncke WH; Emery P; Isaacs JD; Kremer J; Lee EB; Maksymowych WP; Voshaar M; Tam LS; Tanaka Y; van den Bosch F; Westhovens R; Xavier R; Smolen JS
Ann Rheum Dis; 2021 Jan; 80(1):71-87. PubMed ID: 33158881
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy control in patients with systemic lupus erythematosus/antiphospholipid syndrome. Part 2: Pregnancy follow-up.
Rodríguez Almaraz E; Sáez-Comet L; Casellas M; Delgado P; Ugarte A; Vela-Casasempere P; Martínez Sánchez N; Galindo-Izquierdo M; Espinosa G; Marco B; Martínez López JA; Robles A; Martínez-Taboada V; Bartha JL; Ruiz-Irastorza G
Reumatol Clin (Engl Ed); 2021 Mar; 17(3):125-131. PubMed ID: 31780250
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy control in Patients with Systemic Lupus Erythematosus/Antiphospholipid Syndrome. Part 3: Childbirth. Puerperium. Breastfeeding Contraception. Newborn.
Delgado P; Robles Á; Martínez López JA; Sáez-Comet L; Rodríguez Almaraz E; Martínez-Sánchez N; Ugarte A; Vela-Casasempere P; Marco B; Espinosa G; Galindo M; Casellas M; Ruiz-Irastorza G; Martínez-Taboada V; Bartha JL
Reumatol Clin (Engl Ed); 2021 Apr; 17(4):183-186. PubMed ID: 31831386
[TBL] [Abstract][Full Text] [Related]
15. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome.
de Jesús GR; Benson AE; Chighizola CB; Sciascia S; Branch DW
Lupus; 2020 Oct; 29(12):1601-1615. PubMed ID: 32883160
[TBL] [Abstract][Full Text] [Related]
16. Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.
Rubio-Rivas M; Corbella X; Guillén-Del-Castillo A; Tolosa Vilella C; Colunga Argüelles D; Argibay A; Vargas Hitos JA; Todolí Parra JA; González-Echávarri C; Ortego-Centeno N; Trapiella Martínez L; Rodríguez Carballeira M; Marín Ballvé A; Pla Salas X; Perales Fraile I; Chamorro AJ; Madroñero Vuelta AB; Freire M; Ruiz Muñoz M; González García A; Pons Martín Del Campo I; Sánchez García ME; Bernal Bello D; Espinosa G; García Hernández FJ; Sáez Comet L; Ríos Blanco JJ; Fernández de la Puebla Giménez RÁ; Sánchez Trigo S; Fonollosa Pla V; Simeón Aznar CP;
Autoimmun Rev; 2020 May; 19(5):102507. PubMed ID: 32194200
[TBL] [Abstract][Full Text] [Related]
17. Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?
Vera R; Mata E; González E; Juez I; Alonso V; Iranzo P; Martínez NP; López C; Cabrera JM; Safont MJ; Ruiz-Casado A; Salgado M; González B; Escudero P; Rivera F; Pericay C
Int J Colorectal Dis; 2020 Apr; 35(4):739-746. PubMed ID: 32062727
[TBL] [Abstract][Full Text] [Related]
18. Managing antiphospholipid syndrome in pregnancy.
Schreiber K; Hunt BJ
Thromb Res; 2019 Sep; 181 Suppl 1():S41-S46. PubMed ID: 31477227
[TBL] [Abstract][Full Text] [Related]
19. Variation in Colonoscopy Performance Measures According to Procedure Indication.
Mangas-Sanjuan C; Santana E; Cubiella J; Rodríguez-Camacho E; Seoane A; Alvarez-Gonzalez MA; Suárez A; Álvarez-García V; González N; Luè A; Cid-Gomez L; Ponce M; Bujanda L; Portillo I; Pellisé M; Díez-Redondo P; Herráiz M; Ono A; Pizarro Á; Zapater P; Jover R;
Clin Gastroenterol Hepatol; 2020 May; 18(5):1216-1223.e2. PubMed ID: 31446179
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid Syndrome in Renal Allograft Recipients-A Long-Term Multicenter Analysis.
Furmańczyk-Zawiska A; Bułło-Piontecka B; Komorniczak M; Dębska-Ślizień A; Augustyniak-Bartosik H; Durlik M
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
